These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 21123778)

  • 1. Signal/noise ratios to compare tests for measuring visual field progression.
    Ernest PJ
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6893; author reply 6893-4. PubMed ID: 21123778
    [No Abstract]   [Full Text] [Related]  

  • 2. Signal/noise analysis to compare tests for measuring visual field loss and its progression.
    Artes PH; Chauhan BC
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4700-8. PubMed ID: 19458326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual field progression.
    Medeiros FA; Weinreb RN
    Ophthalmology; 2010 Apr; 117(4):851-2; author reply 852. PubMed ID: 20346830
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulsar perimetry in the diagnosis of early glaucoma.
    Gonzalez de la Rosa M
    Am J Ophthalmol; 2011 Sep; 152(3):500-501. PubMed ID: 21855674
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlating Structural and Functional Damage in Glaucoma.
    Torres LA; Hatanaka M
    J Glaucoma; 2019 Dec; 28(12):1079-1085. PubMed ID: 31478953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scanning laser polarimetry and progression of visual field defects after intraocular pressure increase.
    Lopes JF; Susanna R
    Arch Ophthalmol; 2003 Oct; 121(10):1500-1. PubMed ID: 14557197
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of current technology used in evaluating visual function in glaucoma.
    Turalba AV; Grosskreutz C
    Semin Ophthalmol; 2010; 25(5-6):309-16. PubMed ID: 21091017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continued visual field progression in eyes with prior visual field progression in patients with open-angle glaucoma.
    Chen PP; Cady RS; Mudumbai RC; Ngan R
    J Glaucoma; 2010 Dec; 19(9):598-603. PubMed ID: 20179616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flicker-defined form perimetry in glaucoma patients.
    Horn FK; Kremers J; Mardin CY; Jünemann AG; Adler W; Tornow RP
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):447-55. PubMed ID: 25511293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratometry, optic disc dimensions, and degree and progression of glaucomatous optic nerve damage.
    Jonas JB; Stroux A; Martus P; Budde W
    J Glaucoma; 2006 Jun; 15(3):206-12. PubMed ID: 16778642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma.
    Martus P; Stroux A; Budde WM; Mardin CY; Korth M; Jonas JB
    Am J Ophthalmol; 2005 Jun; 139(6):999-1009. PubMed ID: 15953429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and rates of visual field progression after longitudinally measured optic disc change in glaucoma.
    Chauhan BC; Nicolela MT; Artes PH
    Ophthalmology; 2009 Nov; 116(11):2110-8. PubMed ID: 19500850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "Curse" of the Fellow Eye in Glaucoma.
    Varma R; Jiang X
    JAMA Ophthalmol; 2018 Oct; 136(10):1156-1157. PubMed ID: 30098139
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between visual field sensitivity and macular ganglion cell complex thickness as measured by spectral-domain optical coherence tomography.
    Cho JW; Sung KR; Lee S; Yun SC; Kang SY; Choi J; Na JH; Lee Y; Kook MS
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6401-7. PubMed ID: 20631238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of frequency doubling technology (FDT) in glaucoma screening.
    Quaranta GM; Vetrugno M; Trabucco T; Cantatore F; Cardia L
    Acta Ophthalmol Scand Suppl; 2000; (232):21-3. PubMed ID: 11235516
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of optic nerve head topography and visual field in eyes with open-angle and angle-closure glaucoma.
    Boland MV; Zhang L; Broman AT; Jampel HD; Quigley HA
    Ophthalmology; 2008 Feb; 115(2):239-245.e2. PubMed ID: 18082888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships in normal and glaucomatous eyes determined by time- and spectral-domain optical coherence tomography.
    Lee JR; Jeoung JW; Choi J; Choi JY; Park KH; Kim YD
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6424-30. PubMed ID: 20592233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma.
    Chauhan BC; Mikelberg FS; Balaszi AG; LeBlanc RP; Lesk MR; Trope GE;
    Arch Ophthalmol; 2008 Aug; 126(8):1030-6. PubMed ID: 18695095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.